Russell Investments Group’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PLRX
TCM
BOCH
ACM
MAM
PM
Russell Investments Group's PLRX Position: Q1 2026 in Review
Russell Investments Group sold out of Pliant Therapeutics (PLRX) in Q1 2026, closing a stake of 542 shares — an estimated $661 sold.
Russell Investments Group first reported a position in PLRX in Q2 2021 and held it in 19 quarters. The position peaked at $4.77M in Q1 2023. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.
- Russell Investments Group reported no remaining Pliant Therapeutics position as of Q1 2026 after selling out during the quarter.
- Russell Investments Group sold 542 Pliant Therapeutics shares in Q1 2026, an estimated $661.
- Russell Investments Group first reported a position in Pliant Therapeutics in Q2 2021 and held it in 19 quarters.
- Russell Investments Group's Pliant Therapeutics position peaked at $4.77M in Q1 2023.
- 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.